Clinical Trials Browser

Phase 2 × Lung Neoplasms × Endostatins × Clear all

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

Lung Neoplasms